|
Virtus was established in September 2002 and has or is still managing the following clinical trials in South Africa:
| Cardiovascular |
Pulmonary Hypertension |
II |
Swiss based biotech |
| Virology |
HIV |
II |
US based biotech |
| Neurology |
Brain tumour |
II |
Swiss based biotech |
Our strategy is to develop very strong relationships with our clients and to support this with commitment and service. We believe that this strategy differentiates Virtus from others and provides confidence for clients to enjoy a sustainable relationship as projects advance through to Phase III and IV.
Prior to the establishment of Virtus, the management team has had the following clinical development experience:
| Alzheimer's disease |
6 |
US and Canadian based |
| Infectious diseases |
4 |
US, and RSA based |
| Oncology |
1 |
US based |
| Diabetes |
1 |
EU based |
| Ophthalmology |
1 |
US based |
| Rheumatoid arthritis |
1 |
RSA based |
| Psoriasis |
1 |
RSA based |
| Cardiovascular |
1 |
US and UK based |
| III to IV |
1 |
| III |
2 |
| II |
12 |
| I |
1 |
|
